Valuation Zai Lab Limited Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 01:14:34 19/08/2026 pm IST			5-day change	1st Jan Change
22.20 ^EUR	+4.72%		+1.87%	+49.32%

17/08	Zai Lab Limited and Argenx Announces Positive Topline Results From Phase 3 Alkivia Trial Of Efgartigimod In Autoimmune Myositis	CI
13/08	Asian Equities Traded in the US as American Depositary Receipts Marginally Higher in Thursday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,059	2,946	2,688	2,853	1,962	2,871	-	-
Change	-	-51.37%	-8.77%	6.15%	-31.23%	46.32%	-	-
Enterprise Value (EV) ¹	4,650	1,938	1,897	2,095	1,397	2,413	2,490	2,634
Change	-	-58.33%	-2.13%	10.47%	-33.34%	72.78%	3.18%	5.79%
P/E	-8.29x	-6.63x	-7.9x	-10.1x	-11x	-11.3x	-11.9x	-15.5x
PBR	4.35x	-	3.34x	3.36x	2.73x	5.87x	6.5x	6.99x
PEG	-	0.2x	0.3x	0.4x	0.3x	-0.3x	2.39x	0.7x
Capitalization / Revenue	42x	13.7x	10.1x	7.15x	4.26x	6.79x	5.05x	3.99x
EV / Revenue	32.2x	9.01x	7.11x	5.25x	3.04x	5.71x	4.38x	3.66x
EV / EBITDA	-6.7x	-4.89x	-5.3x	-7.75x	-6.51x	-8.3x	-12.7x	-20.9x
EV / EBIT	-6.64x	-4.79x	-5.17x	-7.43x	-6.09x	-8.03x	-12x	-19.7x
EV / FCF	-8.19x	-4.94x	-9.23x	-9.5x	-8.5x	-13.1x	-16.9x	-25.2x
FCF Yield	-12.2%	-20.2%	-10.8%	-10.5%	-11.8%	-7.63%	-5.93%	-3.96%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-7.58	-4.63	-3.46	-2.6	-1.6	-2.265	-2.152	-1.651
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	144.3	215	266.7	399	460.2	422.6	568.9	719.1
EBITDA ¹	-693.6	-396.1	-357.5	-270.3	-214.4	-290.7	-196.7	-126.2
EBIT ¹	-700.1	-404.4	-366.6	-282.1	-229.4	-300.6	-207	-133.5
Net income ¹	-704.5	-443.3	-334.6	-257.1	-175.5	-245.1	-186.9	-168.2
Net Debt ¹	-1,409	-1,008	-791.3	-757.9	-565.3	-457.7	-380.8	-236.7
Reference price ²	62.85	30.70	27.33	26.19	17.64	25.57	25.57	25.57
Nbr of stocks (in thousands)	96,409	95,972	98,349	1,08,937	1,11,219	1,12,266	-	-
Announcement Date	01/03/22	01/03/23	27/02/24	27/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	18.76x	4.38x	10.31x	0.48%	8.09TCr
SAMSUNG BIOLOGICS CO.,LTD.	37.28x	12.74x	24.23x	-.--%	5.01TCr
UCB	21.76x	4.81x	13.74x	0.67%	4.8TCr
CSL LIMITED	18.53x	4x	12.31x	2.68%	5.36TCr
BIOGEN INC.	37.77x	3.48x	13.26x	-.--%	3.14TCr
MODERNA, INC.	-7.34x	10.2x	-6.58x	-.--%	2.51TCr
INCYTE CORPORATION	54.39x	3.5x	27.09x	-.--%	2.5TCr
INNOVENT BIOLOGICS, INC.	71.69x	6.93x	46.4x	-.--%	2.15TCr
SWEDISH ORPHAN BIOVITRUM AB	24.35x	5.22x	13.6x	-.--%	1.69TCr
Average	30.80x	6.14x	17.15x	0.43%	3.92TCr
Weighted average by Cap.	27.62x	6.03x	15.66x	0.61%